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In  previous  reports  we  have  shown  that  pathological  macroglobulins  are 
antigenically  deficient  when  compared  with  normal  19S  ~l-globulin  (1),  and 
that multiple  myeloma proteins  are deficient when  compared with  normal  7S 
"y2-globulin  (2).  Furthermore,  these  multiple  myeloma proteins  contain  anti- 
genic  determinants  that  are  patient-specific  (2);  that  is,  these  proteins  are 
specific for the patient from whom they were obtained. 
It was therefore  of interest  to determine  whether pathological  macroglobu- 
lins, when injected  into rabbits,  might induce antisera specific for pathological 
macroglobulins  or  the  homologous  macroglobulins.  Moreover,  the  hetero- 
geneity  of  the  macroglobulins,  which  consist  of  two  major  components  with 
sedimentation  constants  (s20~) of 19S and 26S raised the question  whether this 
heterogeneity would be reflected immunologically. 
The resulting  experiments have shown  that  the pathological macroglobulins 
contain  two patient-specific  proteins. 
Materials and Methods 
Antig~s.--The  macrogiobulins  have been  described  previously  (1);  they  contained  at 
least two components,  19S and 26S, as determined  by ultraeentrifugal analysis. 
Antisera.--Antisera against normal macrogiobulin have been described (1). Antisera against 
MCG I,  1 MCG III and MG V were prepared by injecting  rabbits twice with 10 to 50 nag. of 
the antigens in Freund adjuvant. These injections were given at weeklyintervals. Three weeks 
after the last injection  the animals were bled.  If the antiserum was sufficiently strong the 
rabbits were exsanguinated,  otherwise  a  third  injection  was admlnlstered  and  the animals 
were exsanguinated  3 weeks later. The gel diffusion technique  has been described  (3). 
* This investigation  was supported by a research grant (C-2359 M  & I) from the National 
Cancer Institute of the National Institute of Health, Public Health Service. 
:~ This work was presented in part at the meeting of the American Association of Immunolo- 
gists, Chicago, April 1957. 
1  The abbreviations MCG and MG stand for macrocryoglobulin  and macrogiobulin  (1). 
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RESULTS 
All antisera obtained at the first bleeding were weak; they either produced 
very faint  lines  or otherwise the  spurs between the homologous and  cross- 
reacting lines were too short for comparative studies. Anti-MeG IB, the anti- 
serum obtained at the second bleeding, was slightly better (Fig.  1), but was by- 
passed for the more potent antiserum obtained at the third bleeding, anti-MeG 
IC serum  (Fig.  3).  The  other antisera  were from  the  second  bleeding.  All 
antisera usually contained antibodies against a E-globulin which were removed 
by absorption with a E-fraction  obtained by zone electrophoresis on starch. 
Since the immunizing  antigens contained small amounts of a component with 
a  sedimentation  constant of 7S it was of interest  to determine whether  the 
antisera would react with normal ~/2-globulin (7S). In our first paper (1) it was 
shown that anti--v2-globulin sera contain antibody against antigenic groupings 
common to the 19S and  7S ~,-globulins as well as antibody specific for  each 
protein.  Consequently,  when  these  antigens  were  compared  with  such  an 
antiserum, the lines intersected (Fig. 2). The anti-MG sera, however, did cross- 
react with the 7S component in the conventional manner; i.e.,  the lines coalesced 
partially because these antisera  contain antibody against groupings that  the 
macroglobulin and  7S globulin have in common as well as antibody against 
groupings specific for the macroglobulins.  No antibody specific for the 7S globu- 
lin could be demonstrated and it may be concluded that the rabbit's response 
was primarily to the injected macroglobulins rather  than  the trace amounts 
of the lighter component. 
When anti-MCG IC, absorbed with ~,~-globulin, was used for comparative 
studies of several macroglobulins,  two spurs  extended beyond the point  of 
fusion of the lines formed by the homologous and heterologous antigens (Fig. 
3).  Consequently, the precipitate formed by the homologous MCG I  should 
consist of two different immunological  systems. Partial absorption of the anti- 
serum with normal "rl-globulin showed this to be the case (Fig. 4). (The normal 
serum actually formed a line which was too faint to be photographed.) Further 
absorption of this antiserum resulted in a  reagent which was specific for the 
homologous antigen  (Fig.  5). Both lines still  show up very clearly; from their 
curvature (1) it can be concluded that the antigens are large,  slowly diffusing 
proteins. They will be referred to as the 19S and 26S components. 
The other anti-macroglobulin sera produced two lines with their homologous 
antigens even prior to absorption (Figs. 6, 7). Absorption of these antisera with 
normal ~,l-globulin made them patient-specific (Figs.  8 to 11),  and again both 
components  of  the  macroglobulin  preparation  contain  the  patient-specific 
determinants. The precipitin pattern with the unabsorbed antisera (Figs. 6, 7) 
shows that one of the macroglobulins has its counterpart in the heterologous 
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component, since it only is present in normal serum in sufficiently high concen- 
tration  to be detected. The lines partially coalesce,  and spurs are formed in- 
dicating that the homologous proteins contain determinants that are unique. 
The second component, 26S, is detectable only in the homologous macroglobu- 
lin,  and  this is true for all  three macroglobulins against which antisera  were 
produced. In the discussion  arguments will be presented suggesting  that  the 
26S  component is  not  completely patient-specific,  but  that  it  shares  a  few 
groupings with normal 19S globulin. 
The fact that spurs are formed between the lines of the homologous and the 
lines of the heterologous 19S globulins, including the normal,  is already sufficient 
evidence  that  the  pathological  macroglobulins  are  antigenically  abnormal. 
These  spurs  are  the product  of an  exhaustive antibody absorption  in situ. 
The limited experience  with this technique, however, made it desirable to test 
the  antisera  in  the  classical  manner  by absorbing  them  with  cross-reacting 
antigen. That our antisera were exhaustively absorbed can be seen from Fig. 12. 
Reservoir A  contains absorbed anti-MCG IC serum,  which no  longer reacts 
with  the macroglobulin  of normal "rl-globulin  (cup B)  or normal  undiluted 
serum. It still reacts with MCG I  in cup D. Cup C contains anti-'r-globulin 
serum C absorbed with ~¢2-globulin. This antiserum reacts with both normal 
and pathological macroglobulin as well as with the normal macroglobulin used 
for the absorption of anti-MCG IC serum, proving that the absorbing antigen 
is in excess. (This proof is an adaptation of the supernatant  test used to de- 
termine the region of antigen excess in the quantitative precipitin reaction (4)). 
The fact that bothlines formed by  the anti-MCG IC serum with MCG I coalesce 
with the line of the anti-~-globulin serum suggests that  the two pathological 
macroglobulins and the normal 19S globulin share the same antigenic grouping 
(See below). 
DISCUSSION 
The first immunological  studies with antisera against sera from patients with 
macroglobulinemia were performed by Habich (5). Using several such antisera 
he found that they precipitated the homologous serum as well as sera from other 
macroglobulinemia patients, even after the antisera were absorbed with normal 
serum.  He also  absorbed one  of his  antisera  with  both  normal  serum  and 
heterologous macroglobulinemia  serum,  and  obtained  a  completely patient- 
specific antiserum.  Most of his results were confirmed  by Kanzow eta/.,  (6). 
More recently Deutsch e~ al. immunized a rabbit with crystalline macroglobu- 
lin (7) isolated from a  patient  with macroglobulinemia  (8).  After absorption 
with a mixture of "rz- and "rl-globulins,  the antiserum failed to react with  the 
homologous antigen. 
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difficult  to determine which antigen(s)  were involved  in  the  imr~unological 
reactions.  This difficulty is eliminated in the Ouchterlony technique because 
each immune system forms a separate line, the curvature of which is characteris- 
tic for the molecular weight of the antigen (9). It is therefore possible to differ- 
entlate precipitates formed by macroglobulins  from those formed by the  7S 
globulin or other contamlnating light proteins. 
In order to study antigenic relationships among different proteins it is essen- 
tial that  the antisera  contain antibody against those antigenic groupings by 
which these proteins may be distinguished.  Failure to find differences  by im- 
munological  techniques does not constitute evidence that a pathological pro- 
rein is normal (7); it only indicates that the antiserum does not contain anti- 
body against a possible abnormal determinant. 
The use of hyperlmmune anti-macroglobulin sera in this study shows that 
pathological macroglobulins contain  at least two antigenic  components,  and 
that both are macroglobulins  according  to the curvature of their precipitin line. 
Whether these two macroglobulins are indeed the 19S and 25S components or 
whether they are two units of the 19S macroglobulin cannot be proven until a 
pure 25S component becomes available. However, since  the antigens contain 
at least 10 per cent of the 25S component and because a molecule of that size 
would diffuse slower than the 19S component, we will assume that it is respon- 
sible for the line closest to the antigen cup. This 26S globulin is detectable only 
in the homologous antigen, suggesting that its antigenic structure is different 
for each patient. Whether such a protein is also present in normal serum is as 
yet undetermined. Wallenins eta/., (10) have shown that repeated ultracentrif- 
ugation of normal Tl-globulin  leads to the accumulation of a 26S component. 
The 19S components of pathological macroglobulins cross-react with normal 
19S globulin and the equivalent proteins from heterologous macroglobulinemic 
sera. The fact that spurs are formed indicates that the homologous 19S globulin 
possesses antigenic groupings that are absent from all other pathological  and 
normal macroglobulins. 
In  previous papers  (1,  11)  it  was shown  that  Bence Jones proteins  (M. 
weight 35,000) qts-globulin  (molecular  weight  150,000) and  19S globulin (M. 
weight 1,000,000) have antigenic groupings in common. It was therefore of in- 
terest to determine whether 25S and 19S were also antigenicaUy related. A direct 
proof is as yet not possible because the 26S globulin is not available as an iso- 
lated protein. Let us therefore turn to the indirect evidence from which it can 
be deduced that these two macroglobulins share the same groupings with normal 
19S TrglobuH-. 
From Fig. 12 it can be seen that the two lines produced by the pathological 
macroglobulins  and homologous antiserum fuse with the single line formed by 
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MCG IC does not react with normal macroglobulin it follows  that  the  two 
antisera  contain  antibodies  against  different  groupings  of  the  pathological 
proteins; i.e., anti-7-globulin serum contains antibodies against groupings that 
the normal and pathological antigens have in common, whereas  the absorbed 
anti-MCG IC serum contains antibody only against those groupings  that are 
unique for MCG I. The formation of two lines with this preparation  and  its 
homologous antiserum  proves  that  the  antiserum  contains  some antibodies 
that  cannot react with the antigen forming the line  closest to the antiserum 
cup; these antibodies react with the slower diffusing component. All antibodies 
of anti-7-globulin  serum react with  the faster diffusing  antigen  of MCG I; 
if the antiserum contained antibody against groupings of the 26S components 
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TEXT-I~0.  1. Evidence for the antigenic relationship of normal macroglobulin and the two 
pathological macroglobulins. 
absent from the 19S protein two lines rather than one should have been formed. 
The fusion of the two lines formed by anti-MCG IC serum with the line formed 
by anti-7-globulin  serum can be best explained  by Text-fig.  1. 
We assume that the two pathological proteins have the following antigenic 
structure:-- 
19S: ax 
26S: ay 
and that anti-MCG IC serum contains anti-x and y antibodies. Anti-'y-globulin 
serum contains only anti-a antibody. 
Anti-x reacts with 19S and is precipitated by it; anti-y diffuses through the 
resulting line and reacts with 26S. Anti-a reacts with 19S and forms a line in 
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edge of this line it will encounter free anti-a antibody and be precipitated so 
that the two precipitates will be superimposed to form one line. The three lines 
formed by the two antisera coalesce because neither groupings x nor y can dif- 
fuse independent of grouping a. 
Recently there has been some controversy in the literature concerning  the 
nature of the elevated serum proteins encountered in multiple myeloma and 
macroglobulinemia  (2, 5,  7). The data presented here and elsewhere  are not 
easily reconciled  with the theory that these proteins are elevated components 
of normal serum constituents; rather, they are best explained by the hypothesis 
that  the  elevated proteins  encountered in  these  two diseases are  abnormal. 
These proteins are abnormal because they are deficient in some of the antigenic 
groupings present in the normal proteins, and they contain groupings that as 
yet have not been demonstrated in normal serum. 
SUMMARY 
Rabbits were  immunized  with three highly purified  macroglobulins,  from 
patients with macroglobulinemia. The antisera reacted with two macroglobu- 
lins with sedimentation constants of 19S and 26S of homologous antigen, and 
cross-reacted with  the  7S  and  19S globulins  of normal "yl-globulin and  the 
heterologous pathological 19S macroglobulins.  Exhaustive absorption of these 
antisera  with normal "},-globulins rendered  them specific for the homologous 
macroglobulins.  The  antigenic properties of the pathological  macroglobulins 
indicate that these proteins are abnormal. 
The technical assistance of Mr. James Scott is acknowledged. 
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FIG. I. Center cup:  anti-MCG IB absorbed with E-globulin. 
A. MCG I  D. MCG I 
B.  MCG II  E.  MG VI 
C.  MG VII  F.  Normal serum 
FIO. 2. 
A. MCG II  C.  ~%-globulin 
B.  anti-~,-globulin serum C absorbed  D.  anti-MCG IIB 
with fr. V and/~-globulins. 
Fro. 3. Center cup: anfi-MCG IC absorbed with 72- and E-globulins. 
A.  MCG I  D.  MCG I 
B.  MGV  E.  MGVI 
C.  MCG II  F.  MG VII 
Fro. 4. Center cup: anti-MCG IC absorbed with/9- and ~%-globulins (incomplete). 
A.  MCG I  D. MCG IV 
B.  MCG II  Y..  MCG III 
C.  MG V  F.  Normal serum 
FIG. S. Center cup: anti-MeG IC absorbed with/~- and ~%-globulins (complete). 
A. MCG I  D. MCG I 
B.  MG V  E.  MCG II 
C.  MG VI  F.  MCG IV 
FIG. 6. Center cup: anti-MCG IIB absorbed  with 72- and/~-globulins. 
A.  MCG II  D.  MCG II 
B.  MCG I  E.  MG VI 
C. MG  V  F. Normal plasma (~) 
FIO.  7.  Center  cup:  anti-MG VB absorbed  with/~-globulins. 
A. MGV  D.  MGV 
B.  MCG I  E.  MG VI 
C.  MCG II  F.  Normal serum  (~) 
FIG. 8. Center cup: anti MCG IIB absorbed with/~ and ~,,-globulins. 
A. MCG II  D. MCG II 
B.  MCG I  E.  MG VI 
C.  MG V  F.  Normal plasma (~) 
FIG. 9. Center  cup: anti-MG VB absorbed with 8- and ~%-globulins. 
A.  MGV 
B.  MCG I 
C.  MCG II 
FIG. 10. 
A. MCG I 
B.  anti-MG VB absorbed with/~- and 
~,l-globulins. 
FIG. 11. 
A.  MCG II 
B.  anti-MG VB absorbed with/~- and 
~n-globulins. 
FIO. 12. 
A.  anti-MCG  IC  absorbed  with  /~- 
and -n-globulins (complete). 
B.  ~%-globulin,  40 mg./ml. 
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D.  MGB 
E.  MGVI 
F.  MGVII 
C.  MGV 
D.  anti-MCG IC absorbed  with 8- 
and ~'l-globulins (incomplete). 
C.  MGV 
D.  anti-MCG II absorbed  with  8- 
and ~/1-globulins. 
C.  anti--,/~-globulin E absorbed with 
fraction V, 15- and 72-globulins. 
D.  MCG I, 3 mg./ml. TtIE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 106  PLATE  40 
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